3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
2
Lymphoma
2
Sarcoma
1
Preleukemia
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Osteosarcoma
1
Neoplasms, Plasma Cell
1
Neoplasms by Histologic Type
1
Neoplasms
1
Myelodysplastic Syndromes
1
Mobility Limitation
1
Melanoma
1
Lymphoproliferative Disorders
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphatic Diseases
1
Leukemia, Myeloid, Acute
1
Leukemia, Myeloid
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Lymphoid
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, Biphenotypic, Acute
1
Leukemia, B-Cell
1
Leukemia
1
Kidney Neoplasms
1
Immunoproliferative Disorders
1
Immune System Diseases
1
Hematologic Diseases
1
Head and Neck Neoplasms
1
Esophageal Neoplasms
1
Interventions
pembrolizumab
3
Paclitaxel
3
Carboplatin
3
ulixertinib
1
trastuzumab deruxtecan
1
trastuzumab biosimilar HLX02
1
trametinib
1
selinexor
1
sapanisertib
1
relatlimab
1
pertuzumab
1
palbociclib
1
osimertinib
1
omipalisib
1
larotrectinib
1
ipatasertib
1
erdafitinib
1
dostarlimab
1
defactinib
1
dabrafenib
1
copanlisib
1
capivasertib
1
binimetinib
1
adavosertib
1
X-Rays
1
Vaginal Smears
1
VMBP protocol
1
Trastuzumab
1
Sutures
1
Sunitinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Uterine Neoplasms
×
Patient Reported Outcome Measures
×
90 days
×
Clear all
No trials found.